Maochao Luo
Overview
Explore the profile of Maochao Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Chen H, Wang K, Zhang L, Huang Z, Liu J, et al.
J Hepatol
. 2024 Oct;
82(1):154.
PMID: 39375066
No abstract available.
2.
Cao J, Zhang Z, Zhou L, Luo M, Li L, Li B, et al.
MedComm (2020)
. 2023 Dec;
4(6):e427.
PMID: 38045829
Emerging evidence indicates that cancer cells can mimic characteristics of embryonic development, promoting their development and progression. Cancer cells share features with embryonic development, characterized by robust proliferation and differentiation...
3.
Li B, Ming H, Qin S, Zhou L, Huang Z, Jin P, et al.
Adv Sci (Weinh)
. 2023 Nov;
11(3):e2306535.
PMID: 37973552
BRAF V600E attracts wide attention in the treatment of colorectal cancer (CRC) as stratifying and predicting a refractory classification of CRC. Recent evidence indicates that Wnt/β-catenin signaling is broadly activated...
4.
He K, Wang Z, Luo M, Li B, Ding N, Li L, et al.
J Transl Med
. 2023 Sep;
21(1):612.
PMID: 37689664
Distant metastasis remains a leading cause of mortality among patients with colorectal cancer (CRC). Organotropism, referring to the propensity of metastasis to target specific organs, is a well-documented phenomenon in...
5.
Jiang J, Chen H, Jin P, Zhou L, Peng L, Huang Z, et al.
Signal Transduct Target Ther
. 2023 Feb;
8(1):65.
PMID: 36788227
The single-nucleotide polymorphism (SNP) of p53, in particular the codon 72 variants, has recently been implicated as a critical regulator in tumor progression. However, the underlying mechanism remains elusive. Here...
6.
Qiao L, Qin S, Weng N, Li B, Luo M, Zhang Z, et al.
Liver Int
. 2023 Feb;
43(4):928-944.
PMID: 36776105
Background And Aims: Human hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. There are limited therapeutic options for those diagnosed with terminal HCC and therefore incorporating novel...
7.
Li L, Jin P, Guan Y, Luo M, Wang Y, He B, et al.
Pharmaceuticals (Basel)
. 2022 Dec;
15(12).
PMID: 36558995
Polyphenol, one of the major components that exert the therapeutic effect of Chinese herbal medicine (CHM), comprises several categories, including flavonoids, phenolic acids, lignans and stilbenes, and has long been...
8.
Li L, Tian H, Zhang Z, Ding N, He K, Lu S, et al.
ACS Appl Mater Interfaces
. 2022 Dec;
15(1):452-468.
PMID: 36538368
Pyroptosis, as a novel mode of cell death, has been proven to have impressive antitumor effects. Dying cells undergoing pyroptosis can elicit antitumor immunity by the release of tumor-associated antigens...
9.
Jia W, Tian H, Jiang J, Zhou L, Li L, Luo M, et al.
Small
. 2022 Nov;
19(2):e2205354.
PMID: 36399643
Durable glioblastoma multiforme (GBM) management requires long-term chemotherapy after surgery to eliminate remaining cancerous tissues. Among chemotherapeutics, temozolomide is considered as the first-line drug for GBM therapy, but the treatment...
10.
Jin P, Jiang J, Zhou L, Huang Z, Qin S, Chen H, et al.
EMBO Mol Med
. 2022 Nov;
14(12):e16082.
PMID: 36321555
Metformin, a well-known antidiabetic drug, has been repurposed for cancer treatment; however, recently observed drug resistance and tumor metastasis have questioned its further application. Here, we found that long-term metformin...